Changyanning Tablet for the Treatment of Diarrhea-Predominant Irritable Bowel Syndrome (IBS-D)
Clinical trial NCT05687435 · COMPLETED
Trial details
- NCT number
- NCT05687435
- Sponsor
- Mei Han
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2023-01-30
- Primary completion
- 2024-04-29
- Enrollment
- 240
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.